ARTICLE | Company News
Swiss Viollier AG sales and marketing update
June 29, 2009 7:00 AM UTC
Swiss Viollier launched its colorectal cancer diagnostic in the EU. The assay is based on the methylated septin 9 (SEPT9) biomarker from Epigenomics AG (Xetra:ECX, Berlin, Germany). The blood-based ...